The development of porous alginate/elastin/PEG composite matrix for cardiovascular engineering.
The development of suitable three-dimensional matrices for the maintenance of cellular viability and differentiation is critical for applications in tissue engineering and cell biology. To this end, gel matrices of different proportions of alginate/elastin/polyethylene glycol (Alg/Ela/PEG) were prepared and examined. The composite matrix membranes were evaluated for their porous scaffold using SEM, enzymatic degradation and water content. An equal blend of Alg/Ela with a ratio of Alg/Ela: PEG (7:3) was selected for fabricating Alg/Ela/PEG scaffolds for this study. The Alg/Ela/PEG membranes fabricated at 20 degrees C and - 20 degrees C had a mean surface pore size of 35-45 microm. However, their ultrastructures had shown bigger pore structures (60-75 microm) compared to their surface. It is interesting to note that the membranes of Alg/Ela/PEG prepared at 20 degrees C had larger ultrastructural pores than that of membranes prepared at -20 degrees C. Further, the SEM studies revealed that in the absence of PEG the composite membranes of Alg/Ela formed with less porous structures. The water content of membranes prepared at 20 degrees C was higher with Alg/Ela/PEG (61.6 +/- 4.8%), compared to Alg/Ela (49.9 +/- 0.3%). The enzymatic degradation and water content studies also revealed that the membranes fabricated at - 20 degrees C had high water uptake and low enzymatic degradation, as that of the membranes prepared at 20 degreees C. In other words the larger pore structured membranes had less water content and high degradation profile. This study proposes that this novel composite matrix produces a hierarchical structure that is useful for generating tissue scaffolds for repairing the failing cardiac muscles. However, more detailed investigations with cytocompatibility studies are needed to find applications.
Chandy
Thomas
T
Department of Cardiology, University of Minnesota, MMC # 508, 420 Delaware Street SE, Minneapolis, MN 55455, USA. tchandy@chfsolutions.com
Rao
Gundu H R
GH
Wilson
Robert F
RF
Das
Gladwin S
GS
D000464:Alginates / Q000737:chemistry*; D001672:Biocompatible Materials / Q000138:chemical synthesis / Q000737:chemistry*; D002454:Cell Differentiation; D002470:Cell Survival; D004549:Elastin / Q000737:chemistry*; D010450:Endopeptidases / Q000737:chemistry; D020723:Glucuronic Acid; D006603:Hexuronic Acids; D006801:Humans; D008422:Materials Testing; D008567:Membranes, Artificial; D008855:Microscopy, Electron, Scanning; D009206:Myocardium / Q000166:cytology; D011092:Polyethylene Glycols / Q000737:chemistry*; D016062:Porosity; D013696:Temperature; D023822:Tissue Engineering / Q000295:instrumentation; D014867:Water / Q000737:chemistry
D000464:Alginates; D001672:Biocompatible Materials; D006603:Hexuronic Acids; D008567:Membranes, Artificial; D014867:Water; D011092:Polyethylene Glycols; D020723:Glucuronic Acid; D004549:Elastin; D010450:Endopeptidases